SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004106
Filing Date
2021-11-10
Accepted
2021-11-10 16:23:34
Documents
67
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sbtx-20210930.htm   iXBRL 10-Q 2527446
2 EX-10.1 sbtx-ex10_1.htm EX-10.1 236775
3 EX-31.1 sbtx-ex31_1.htm EX-31.1 19088
4 EX-31.2 sbtx-ex31_2.htm EX-31.2 19087
5 EX-32.1 sbtx-ex32_1.htm EX-32.1 23907
6 GRAPHIC img42437169_0.jpg GRAPHIC 2710
7 GRAPHIC img42437169_1.jpg GRAPHIC 1187
8 GRAPHIC img238297117_0.jpg GRAPHIC 49685
  Complete submission text file 0000950170-21-004106.txt   7257519

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sbtx-20210930_lab.xml EX-101.LAB 327298
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sbtx-20210930_def.xml EX-101.DEF 133301
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sbtx-20210930_pre.xml EX-101.PRE 247832
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sbtx-20210930.xsd EX-101.SCH 38194
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sbtx-20210930_cal.xml EX-101.CAL 35410
14 EXTRACTED XBRL INSTANCE DOCUMENT sbtx-20210930_htm.xml XML 1001536
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39756 | Film No.: 211397026
SIC: 2834 Pharmaceutical Preparations